u/GWillHunting

I’m genuinely dumbfounded how you can be first to market at an injectable GLP-1, have tons of patients taking it, get first to market with the best oral GLP-1 with thousands of prescriptions for it… and still be only up 1.25% from 5 years ago before your GLP-1 medications were even released.

Like how bad must the upper level management be? Are they just hemorrhaging money or paying out crazy salaries to their upper level c-suite?

Again, developing one of the biggest breakthroughs in modern medicine and yet only being up 1.25% in five years… is nuts. Sure, the IV injectable isn’t as good as LLY. But the oral medication is best in its class and has a huge market and demand for patients across the world.

It’s down 4% today and I just can’t wrap my head around how this company isn’t printing money aside from just horrible, horrible, upper level management or frankly fraud at the upper levels. End rant.

I know we’ve had a bit of a run up the past month, but it’s still insane to me that the stock is only up 23% in five years.

Only up 23% in five years time after developing a blockbuster GLP-1 drug and now the first oral GLP-1 to market.

Like how are they not insanely profitable? How is this company this poorly run to have this kind of return?

It’s truly mind boggling how bad management must be at the upper levels to have this bad of a return on investment for such a successful and profitable drug.